TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
NordicBiocube AB
Closing information (x1000 SEK)
Closing information | 2024/01 | 2023/01 | 2022/01 |
Turnover |
945
|
1,145
|
845 |
Financial expenses |
22
|
5
|
0 |
Earnings before taxes |
-222
|
-140
|
7 |
EBITDA |
-140
|
-69
|
16 |
Total assets |
649
|
856
|
295 |
Current assets |
67
|
215
|
81 |
Current liabilities |
153
|
247
|
34 |
Equity capital |
53
|
99
|
189 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Solvency |
8.2%
|
11.6%
|
64.1% |
Turnover per employee |
945
|
572
|
422 |
Profit as a percentage of turnover |
-23.5%
|
-12.2%
|
0.8% |
Return on assets (ROA) |
-30.8%
|
-15.8%
|
2.4% |
Current ratio |
43.8%
|
87.0%
|
238.2% |
Return on equity (ROE) |
-418.9%
|
-141.4%
|
3.7% |
Change turnover |
-200
|
300
|
314 |
Change turnover % |
-17%
|
36%
|
59% |
Chg. No. of employees |
-1
|
0
|
-1 |
Chg. No. of employees % |
-50%
|
0%
|
-33% |
Total value of public sale
Fiscal year | 2024/01 | 2023/01 | 2022/01 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.